Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Bringing the genomic landscape of small-cell lung cancer into focus

Genomic characterization efforts in small-cell lung cancer have been complicated by the paucity of high-quality surgical resection specimens for this aggressive lung cancer subtype that is usually diagnosed at unresectable stages in small biopsies or cytology specimens. Now, two papers report genomic analyses of small-cell lung cancer, highlighting subsets of tumors driven by amplification of FGFR1, SOX2 or MYC family members or by a MYCL1 fusion oncogene, among many other recurrent alterations.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Major shared versus subtype-associated cancer-related genes in the three common subtypes of lung cancer.

References

  1. Chute, J.P., Chen, T., Feigal, E., Simon, R. & Johnson, B.E. J. Clin. Oncol. 17, 1794–1801 (1999).

    Article  CAS  Google Scholar 

  2. Rudin, C.M. et al. Nat. Genet. 44, 1111–1116 (2012).

    Article  CAS  Google Scholar 

  3. Peifer, M. et al. Nat. Genet. 44, 1104–1110 (2012).

    Article  CAS  Google Scholar 

  4. Pao, W., Iafrate, A.J. & Su, Z. J. Pathol. 223, 230–240 (2011).

    Article  CAS  Google Scholar 

  5. Weiss, J. et al. Sci. Transl. Med. 2, 62ra93 (2010).

    Article  CAS  Google Scholar 

  6. The Cancer Genome Atlas Research Network. Nature published online; doi:10.1038/nature11404 (9 September 2012).

  7. Pleasance, E.D. et al. Nature 463, 184–190 (2010).

    Article  CAS  Google Scholar 

  8. Mäkela, T.P., Saksela, K., Evan, G. & Alitalo, K. EMBO J. 10, 1331–1335 (1991).

    Article  Google Scholar 

  9. Takahashi, K. & Yamanaka, S. Cell 126, 663–676 (2006).

    Article  CAS  Google Scholar 

  10. Tompkins, D.H. et al. PLoS One 4, e8248 (2009).

    Article  Google Scholar 

  11. Chen, S. et al. PLoS One 7, e36326 (2012).

    Article  CAS  Google Scholar 

  12. Pardo, O.E. et al. Cancer Res. 69, 8645–8651 (2009).

    Article  CAS  Google Scholar 

  13. Bass, A.J. et al. Nat. Genet. 41, 1238–1242 (2009).

    Article  CAS  Google Scholar 

  14. Rekhtman, N. Arch. Pathol. Lab. Med. 134, 1628–1638 (2010).

    PubMed  Google Scholar 

  15. Rekhtman, N. et al. Clin. Cancer Res. 18, 1167–1176 (2012).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marc Ladanyi.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Supplementary information

Supplementary Table 1

Past and Current Clinical trials of Targeted Agents in SCLC (PDF 29 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Pietanza, M., Ladanyi, M. Bringing the genomic landscape of small-cell lung cancer into focus. Nat Genet 44, 1074–1075 (2012). https://doi.org/10.1038/ng.2415

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ng.2415

This article is cited by

Search

Quick links

Nature Briefing: Cancer

Sign up for the Nature Briefing: Cancer newsletter — what matters in cancer research, free to your inbox weekly.

Get what matters in cancer research, free to your inbox weekly. Sign up for Nature Briefing: Cancer